Twenty people in Japan who took an Amgen (AMGN) rare immune-disease drug have died, according to the company that sells the Medicine in Japan; US drug regulators had asked Amgen to voluntarily withdraw the drug

The report of twenty deaths linked to Amgen's rare immune-disease drug in Japan raises significant concerns about regulatory scrutiny and public safety, prompting US drug regulators to recommend a voluntary withdrawal of the medication.

Newsquawk StaffPublished 15 May 2026, 20:00 UTCOn the live feed at 19:40 UTC, 20 minutes before this page

Newsquawk headlinesUTC

20:20

Advanced Micro Devices (AMD) enters credit agreement and provides five-year USD 5bln unsecured revolving credit facility

20:03

Newsquawk US Market Wrap: Stocks sold in risk-off trade amid rise in global yields

19:40

Twenty people in Japan who took an Amgen (AMGN) rare immune-disease drug have died, according to the company that sells the Medicine in Japan; US drug regulators had asked Amgen to voluntarily withdraw the drug

19:38

Canada PM Carney says think there will be a lot of interest in a new crude pipeline from Alberta to Pacific Coast

19:22

TREASURY WRAP: T-NOTE FUTURES (M6) SETTLE 30 TICKS LOWER 109-05+

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free

Free. No signup, no card.

Context

This development could lead to increased volatility in Amgen's stock and broader implications for the biotech sector as market participants reassess the risk profile of pharmaceutical investments. Additionally, this may spill over into commodities, especially if fears about regulatory crackdowns heighten investor caution around healthcare stocks and related sectors.

Equities · last 90 days

Recent headlines that moved markets

EQUITIES/8 Sept · 05:24 UTC

Saudi Energy Minister says a number of energy facilities and utilities were hit; are temporarily halting some operations.

Equity indices, after we published−0.3%

Modest downside seen across equity futures as energy prices tick higher.

EQUITIES/3 Sept · 04:54 UTC

North Korea stripped references to "peaceful unification" with South Korea from the charter of its ruling Workers' Party of Korea, according to Yonhap.

Equity indices, after we published−3.3%

EQUITIES/1 Sept · 16:17 UTC

Initial reports of an American attack on Iran, reports i24's Stein.

ES, after we published−0.2%

EQUITIES/26 Aug · 12:56 UTC

States and Meta (META) and agree to settle claims that platforms harmed children, according to a court filing; Meta agrees to pay a maximum of USD 16.68bln to states as part of deal

Market, after we published+2.6%

EQUITIES/7 Sept · 10:54 UTC

Saudi Aramco Jizan oil facilities were reportedly hit in new strikes, the FT reports citing sources; hit on Monday, damage is being assessed.

Equity indices, after we published−0.1%

EQUITIES/7 Sept · 09:15 UTC

Volkswagen (VOW3 GY) says that the Co., Lower Saxony and Aurelius Capital have agreed on key terms for the sale of Osnabrueck Plant; aims to secure the site and majority of jobs in the long term.

Market, after we published+1.6%

Newsquawk Daily

Get both market opens in your inbox.

This note and the other one — the EU open and the US open, every business day, written by the desk. No account needed.

Related headlines

The whole workspace, free to try.

© 2026 Newsquawk. All rights reserved.